Novel algorithm predicts drug combinations to treat drug resistant fungal infections

July 14, 2016

Scientists have created an algorithm that can identify drug combinations to treat fungal infections that have become resistant to current drug treatments. This new study, published in PLOS Computational Biology, represents a strategy for treating complex diseases and finding new uses for existing drugs.

Fungal infections are one of the leading causes of hospital-acquired infections and are therefore associated with high mortality rates due to growing populations of patients with . Unfortunately, drug resistance is common for fungus-causing diseases and so there is an urgent need to develop new therapies to overcome this.

Drug combinations have been widely used in biomedical research and medical practices for treating various diseases. In particular, synergistic drug combinations are an effective strategy to overcome drug resistance, increase treatment efficacy and decrease drug dosage to avoid toxicity. Traditionally, effective drug combinations have been identified through experimentally screening all possible combinations of a pre-defined set of drugs - which is expensive, time consuming and labour intensive.

The authors, led by Professor Yan Guiying from the Chinese Academy of Sciences, created a novel algorithm termed Network-based Laplacian regularized Least Square Synergistic drug combination prediction (NLLSS), to predict potential synergistic drug combinations. It does this by integrating different kinds of information such as known synergistic drug combinations, drug-target interactions and drug chemical structures.

The study then uses NLLSS to predict antifungal synergistic drug combinations for the fungal pathogen Candida albicans. This pathogen causes candidiasis which develops into the fourth most common fungal blood stream infection among hospitalized patients in the United States - according to the Centers for Disease Control & Prevention. Using NLLSS, the scientists, led by Prof. Zhang Lixin from the Chinese Academy of Sciences, experimentally validated 7 out of 13 predicted antifungal synergistic drug combinations for Candida albicans - which could provide new treatments and work towards overcoming fungal for this pathogen.

This research shows that NLLSS is an efficient strategy to identify potential synergistic antifungal combinations, explore new indications of existing drugs, and provide useful insights into the underlying molecular mechanisms of synergistic .

Explore further: Drug combinations a good approach for infectious fungus, research shows

More information: PLOS Computational Biology, dx.plos.org/10.1371/journal.pcbi.1004975

Related Stories

Drug combinations a good approach for infectious fungus, research shows

February 6, 2015
Researchers at the University of Toronto have discovered that Candida albicans—a leading cause of potentially fatal hospital-acquired infections—rarely develops resistance to combination drug therapy and, when it becomes ...

Massive screen of drug combinations may find treatment for resistant, BRAF-mutant melanoma

October 26, 2015
A team of Massachusetts General Hospital (MGH) investigators has discovered a new combination of drugs that may be effective against one of the deadliest cancers, malignant melanoma. The combination - pairing a drug targeted ...

Researchers create genetic blueprint of cunning tuberculosis bacteria

June 6, 2016
The rise in multi-drug resistant (MDR) and extremely drug resistant (XDR) strains of Mycobacterium tuberculosis (MTB) is becoming a major cause of global health concern for treating tuberculosis, which affects a third of ...

'Imperfect drug penetration' speeds pathogens' resistance, study finds

May 18, 2015
Prescribing patients two or more drugs that do not reach the same parts of the body could accelerate a pathogen's resistance to all of the drugs being used in treatment, according to a new study published today in the Proceedings ...

New drug combinations could significantly improve tuberculosis treatment

March 28, 2016
Researchers from UCLA and Shanghai Jiao Tong University have made an important step toward a substantially faster and more effective treatment for tuberculosis, which infects some 10 million people and causes 1.5 million ...

Recommended for you

New cellular approach found to control progression of chronic kidney disease

December 15, 2017
Researchers have demonstrated for the first time that extracellular vesicles - tiny protein-filled structures - isolated from amniotic fluid stem cells (AFSCs) can be used to effectively slow the progression of kidney damage ...

Testing shows differences in efficacy of Zika vaccines after one year

December 15, 2017
(Medical Xpress)—A large team of researchers with members from Harvard Medical School, Walter Reed Army Institute of Research, Bioqual Inc. and MIT has found that the efficacy of the three types of Zika vaccines currently ...

How to regulate fecal microbiota transplants

December 15, 2017
(Medical Xpress)—A small team of researchers at the University of Maryland, some with affiliations to the Veterans Affairs Maryland Health Care System, has written and published a Policy Forum piece in the journal Science ...

Screening could catch a quarter of hip fractures before they happen

December 15, 2017
Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women - according to new research led by the University of East Anglia (UEA).

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

40 years after first Ebola outbreak, survivors show signs they can stave off new infection

December 14, 2017
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.